Leading Life Technologies (LLT) transforms better data into better research, diagnostics, and patient care.
At the heart of LLT is FocalTuning™, our proprietary universal immunoassay platform. Designed for accurate detection of biomarkers and low-abundance analytes in complex biological samples, FocalTuning™ can be adapted to diverse medical fields, with potential applications in the early detection and diagnosis of cancer, Alzheimer’s disease, and other serious conditions.
Detection of anti-PEG IgE for monitoring PEG sensitization and anaphylaxis is the first flagship application bringing FocalTuning™ to market—and a powerful demonstration of the platform’s broader potential.
Vision: A next-generation diagnostics company
Mission: Better data. Better patient outcomes
Strategy: Interdisciplinary
Purpose: Improving research and health
As the years come and go, LLT extends our heartfelt best wishes to everyone working to advance science and human health. Your dedication inspires us every day to develop high-quality, innovative solutions that support life-changing research, diagnostics, and therapies. We are honored to be part of your journey and look forward to building a healthier future together.